(Q57903888)
Statements
Phase II study of pegylated liposomal doxorubicin in heavily pretreated epithelial ovarian cancer patients. May a new treatment schedule improve toxicity profile? (English)
Naldini A
Testa A
D'Agostino G
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference